COMBINED SYK AND JAK INHIBITION BY CERDULATINIB INDUCES APOPTOSIS IN CLL AND OVERCOMES RESISTANCE TO IBRUTINIB

EHA Library, Lynn Wang, 132566

DNA REPLICATION CONTROL MECHANISMS INVOLVED IN CHEMORESISTANCE OF CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Srdana Grgurevic, 132567

ARSENICTRIOXIDE REGULATES CHRONIC LYMPHOCYTIC LEUKEMIA PROLIFERATION BY TARGETING XPO1/SURVIVIN PATHWAY SIGNALLING

EHA Library, Xiaohui Zhang, 132568

IBRUTINIB STIMULATES IL-10 SECRETION BY NLCS, MEDIATING A PARTIAL PROTECTION OF CLL CELLS FROM APOPTOSIS

EHA Library, Stefania Fiorcari, 132569

LEUKEMIC CELL/MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA: ROLE OF JAK2/STAT3 AXIS IN THE SURVIVAL OF NEOPLASTIC CLONE

EHA Library, Filippo Severin, 132570

LINKING PROTEOME AND GENOME FOR BIOMARKER DISCOVERY IN CLL – ESTABLISHMENT OF A CLL PROTEIN DATABASE

EHA Library, Gina Eagle, 132571

THE IMPACT OF THE TUMOUR MICROENVIRONMENT ON B-CELL RECEPTOR (BCR) EXPRESSION AND SIGNALLING IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL).

EHA Library, Rachel Dobson, 132572

INHIBITION OF USP7 INDUCES SELECTIVE CANCER CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA THROUGH PTEN AND INDEPENDENTLY FROM P53 STATUS

EHA Library, Giovanna Carrà, 132573

DIRECT AND INDIRECT MODULATION OF MACROPHAGES IN THE TUMOR MICROENVIRONMENT UPON GENOTOXIC STRESS ALTERS PHAGOCYTIC FUNCTION

EHA Library, Daniela Vorholt, 132574

NF-ΚB INDUCES IL-6-MEDIATED STAT3-PHOSPHORYLATION IN CLL CELLS

EHA Library, Uri ROZOVSKI, 132575

DIFFERENTIAL EXPRESSION PROFILE OF H/ACA RIBONUCLEOPROTEIN COMPONENTS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS

EHA Library, Patricia Dos Santos, 132576

REDOX SIGNALING HYPERSENSITIVITY DISTINGUISHES CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH FAVORABLE PROGNOSIS

EHA Library, Maria T Scupoli, 132577

OFATUMUMAB AND LENALIDOMIDE PREFERENTIALLY INHIBIT B-CELL RECEPTOR SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS WITH MUTATED IGHV

EHA Library, Chiara Cavallini, 132578

DECREASED EXPRESSION OF WNT3, A CANONICAL WNT PATHWAY LIGAND, IS FREQUENT IN CHRONIC LYMPHOCYTIC LEUKEMIA PROGRESSION AND IDENTIFIES PATIENTS WITH SHORT TREATMENT-FREE SURVIVAL IN MUTATED IGHV SUBSET

EHA Library, Lucie Poppova, 132579

INNATE LYMPHOID CELLS ARE EXPANDED AND FUNCTIONALLY ALTERED IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Iris De Weerdt, 132580

IN VITRO EVALUATION OF BORTEZOMIB MOLECULAR EFFECTS IN LARGE GRANULAR LYMPHOCYTE LEUKEMIA

EHA Library, Giulia Calabretto, 132581

A SHARP CONTRAST IN FUNCTIONALITY BETWEEN EBV- AND CMV-SPECIFIC CD8+ T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Tom Hofland, 132582

IDENTIFICATION OF A STRUCTURALLY NOVEL BTK MUTATION THAT DRIVES IBRUTINIB RESISTANCE IN CLL BUT NOT RICHTER TRANSFORMATION

EHA Library, Lynn Wang, 132583

CHECKPOINT KINASE 1 INHIBITION POTENTIATES APOPTOSIS AND INFLICTS MITOTIC FAILURE IN CLL-DERIVED MEC-1 CELL LINE

EHA Library, Jana Zemanova, 132584

PROGNOSTIC SIGNIFICANCE OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 5 AND 5B EXPRESSION IN EPSTEIN-BARR VIRUS POSITIVE PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Panagiotis Diamantopoulos, 132585

EX VIVO LYMPH NODE NATIVE MICROENVIRONMENT ASSAY SHOWS NOVEL ANTIPROLIFERATIVE ACTIVITY FOR IDELALISIB AND IBRUTINIB ON CLL CELLS

EHA Library, Juan Ballesteros, 132586

THE RETINOID DRUG ACITRETIN UPREGULATES CD38 EXPRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA AND MEC-1 CELLS AND REDUCES CELL HOMING TOWARDS THE CHEMOKINE CXCL12 : POTENTIAL FOR EXPLOITATION IN THERAPY

EHA Library, Sally Elsir Mohammed, 132587

ARRAY CGH ANALYSIS REVEALS DELETION OF CHROMOSOME 22Q11 IN CLL WITH NORMAL KARYOTYPE AND NO FISH ALTERATIONS.

EHA Library, Francesca Mestichelli, 132588

EXPRESSION OF FCGAMMARIIB PREDICTS TIME TO TREATMENT IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Rosa Bosch, 132589

FYN INHIBITOR INDUCES APOPTOSIS IN NK LEUKEMIA CELLS

EHA Library, Ilaria Laurenzana, 132590

RETROTRANSPOSONS SHAPED NON-REDUNDANT CLLU1 GENE MODULES

EHA Library, Spyros Papamichos, 132591

AMONG CLL PATIENTS WITH MULTIPLE FISH ABNORMALITIES, 13Q AND 11Q DELETIONS ENTAIL THE COMMONEST COMBINATION IN CONTRAST TO 11Q AND 17P DELETIONS, BEING THE COMBINATION WITH WORSE OUTCOME

EHA Library, Isabel González-Gascón y Marín, 132592

FUNCTIONAL ROLE OF PI3K-DELTA IN MALIGNANT B CELLS

EHA Library, Lars Neumann, 132593

ACTIVATION INDUCED DEAMINASE SPLICE VARIANTS EXPRESSED IN B CELL LEUKEMIA AND LYMPHOMA DO NOT RETAIN THEIR CATALYTIC ACTIVITY

EHA Library, Kristína Zápražná, 132594

CHROMOSOMAL GAINS IN CHRONIC LYMPHOCYTIC LEUKEMIA: A RARE EVENT ASSOCIATED WITH A DISMAL PROGNOSIS

EHA Library, Isabel González-Gascón y Marín, 132595

TWO-DIMENSIONAL GEL ELECTROPHORESIS(2-DE) ANALYSIS REVEALS DIFFERENTIALLY EXPRESSED PROTEIN PATTERNS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AFTER THYMOSIN Β4 (TB4) AND LENALIDOMIDE (LEN) TREATMENT

EHA Library, Sabrina Bossio, 132596

A COMPARATIVE STUDY ON THE EFFECTS OF NUTLIN-3A IN B-CLL CHRONIC LYMPHOCYTIC LEUKEMIA CELLS WITH AND WITHOUT 17P DELETION

EHA Library, Medhat Shehata, 132597

DNA-DEPENDENT TRANSCRIPTIONAL REGULATORY GENES WERE HYPOMETHYLATED IN KOREAN CHRONIC LYMPHOCYTIC LEUKEMIA – A METHYLCPG BINDING DOMAIN NGS STUDY

EHA Library, Young Kyung Lee, 132598

INCREASED EXPRESSION OF PIM2 GENE IS ASSOCIATED WITH POOR PROGNOSIS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA.

EHA Library, Katarzyna Kapelko-Slowik, 132599

SURVIVAL IN CHRONIC LYMPHOCYTIC LEUKEMIA: A POPULATION-BASED STUDY INCLUDING 13,034 PATIENTS DIAGNOSED IN 1982–2013 IN SWEDEN

EHA Library, Vilhjálmur Steingrímsson, 132600

IDELALISIB IN COMBINATION WITH BENDAMUSTINE/RITUXIMAB IMPROVES OVERALL SURVIVAL IN PATIENTS WITH RELAPSED/REFRACTORY CLL: INTERIM RESULTS OF A PHASE 3 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY

EHA Library, Peter Hillmen, 132601

PRELIMINARY RESULTS OF A PHASE I/IB STUDY OF IBRUTINIB IN COMBINATION WITH TGR-1202 IN PATIENTS WITH RELAPSED/REFRACTORY CLL OR MCL

EHA Library, Matthew Davids, 132602

CLINICAL EPIDEMIOLOGY OF CLL AND CYTOGENETIC ABNORMALITIES: ASSOCIATION OF UNIQUE EPIDEMIOLOGIC EXPOSURES WITH 17P OR 11Q DELETION IN NEWLY-DIAGNOSED CLL

EHA Library, James M Foran, 132603

ASSESSING TIME TO FIRST TREATMENT IN EARLY CLL: A COMPARATIVE PERFORMANCE ANALYSIS OF FIVE PROGNOSTIC MODELS WITH INCLUSION OF CLL-IPI.

EHA Library, Stefano Molica, 132604

BCL6 ABNORMALITIES ON FLUORESCENCE IN SITU HYBRIDIZATION ARE ASSOCIATED WITH EARLY AGE AT DIAGNOSIS, KARYOTYPIC COMPLEXITY, AND AGGRESSIVE DISEASE IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Patrick Eulitt, 132605

VERY YOUNG PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA HAVE LOWER INCIDENCE OF ADVERSE CYTOGENETICS AND IMPROVED OVERALL SURVIVAL: 10-YEAR EXPERIENCE FROM MEMORIAL SLOAN KETTERING CANCER CENTER.

EHA Library, Bartlomiej Getta, 132606

CD49D EXPRESSION IS ASSOCIATED WITH DEVELOPMENT OF LYMPHADENOPATHY IN PATIENTS WITH MONOCLONAL B-CELL LYMPHOCYTOSIS (MBL) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, Paolo Strati, 132608

IMPACT OF THE APOPTOTIC REGULATOR DRAK2 IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Meera soundararajan, 132609

THE PROGNOSTIC SIGNIFICANCE OF PROLYMPHOCYTES IN CLL AND CORRELATION WITH MOLECULAR MARKERS IN THE LRF CLL4 TRIAL

EHA Library, Daniel Catovsky, 132610

ITALIAN VALIDATION OF THE INTERNATIONAL PROGNOSTIC INDEX FOR CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS (CLL-IPI) AND COMPARISON WITH MDACC PROGNOSTIC INDEX: ANALYSIS OF 620 CASES

EHA Library, Massimo Gentile, 132611

IDELALISIB PLUS AN ANTI-CD20 ANTIBODY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WHO ARE HBV CORE ANTIBODY POSITIVE: SIMILAR PATTERNS OF LIVER TEST ABNORMALITIES

EHA Library, Tadeusz Robak, 132612

SECONDARY CANCERS, MAJOR INFECTIONS AND AUTOIMMUNE DISEASES OCCUR IN DIFFERENT SUBSETS OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Andrea Visentin, 132613

HYPOGAMMAGLOBULINEMIA IN CHRONIC LYMPHOCYTIC LEUKEMIA: CLINICOBIOLOGICAL ASSOCIATIONS

EHA Library, Panagiotis Baliakas, 132614

THE ASSOCIATION OF DYSLIPIDEMIA WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A POPULATION-BASED STUDY

EHA Library, Lee Mozessohn, 132615

PATTERNS OF IDELALISIB TREATMENT-EMERGENT LYMPHOCYTOSIS IN PATIENTS WITH CLL OR SLL

EHA Library, Paolo Ghia, 132616

RESULTS OF PROSPECTIVE OBSERVATIONAL TRIAL OF POLISH ADULT LEUKEMIA GROUP (PALG) ON IBRUTINIB COMPASSIONATE USE IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) IN POLAND.

EHA Library, Krzysztof Jamroziak, 132617

SF3B1 MUTATIONS, IGHV MUTATION STATUS AND ABNORMALITIES DETECTED BY GENOMIC ARRAYS DETERMINE PROGNOSIS IN CLL WITH NORMAL KARYOTYPE

EHA Library, Calogero Vetro, 132618

A SYSTEMATIC LITERATURE REVIEW OF RANDOMIZED CONTROLLED TRIALS FOR THE TREATMENT OF RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Juliette Thompson, 132619

PREVALENCE OF AGE-RELATED CLONAL HEMATOPOIESIS (ARCH) AND LOW FREQUENCY MUTATIONS IN CLL & MONOCLONAL B LYMPHOCYTOSIS: A MAYO CLINIC EXOME SEQUENCING COHORT STUDY

EHA Library, James M Foran, 132620

PERFORMANCE STATUS AND COMORBIDITY AFFECT SURVIVAL IN ELDERLY PATIENTS WITH CLL AFTER LOW DOSE ALEMTUZUMAB COMBINED WITH CHEMOTHERAPY: RESULTS FROM THE HOVON68 TRIAL.

EHA Library, Fie Vojdeman, 132621

OUR APPROACH TO HAIRY CELL LEUKEMIA (HCL): 31 YEARS OF EXPERIENCE

EHA Library, Pinar Ataca, 132622

ARRAY COMPARATIVE GENOMIC HYBRIDIZATION HAS PROGNOSTIC VALUE IN CHRONIC LYMPHOCYTIC LEUKEMIA BEYOND STANDARD FLUORESCENCE IN SITU HYBRIDIZATION

EHA Library, Brendan Beaton, 132623

RISK FACTORS AND PROFILE OF INFECTIONS ON IBRUTINIB THERAPY OUTSIDE CLINICAL TRIALS: A SINGLE CENTER EXPERIENCE OF 68 PATIENTS.

EHA Library, Caroline Protin, 132624

IMPACT OF ANTI-CD20 ANTIBODIES ON THE INCIDENCE OF SECONDARY CANCERS INPATIENTS TREATED FOR CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Stéphanie Guidez, 132625

BACH2 AND BCL6 COOPERATIVELY FUNCTION AS TUMOUR SUPPRESSORS IN CLL

EHA Library, Jeyanthy Eswaran, 132626

IMPORTANCE OF PHARMACIST CONSULTATION TO PREDICT EARLY TOXICITIES WITH IBRUTINIB AND IDELALISIB: A SURVEY FROM 119 PATIENTS TREATED IN A SINGLE INSTITUTION

EHA Library, Loïc Ysebaert, 132627

IBRUTINIB FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): IMPACT OF THE YOU&I™ PATIENT SUPPORT PROGRAM ON TREATMENT ADHERENCE

EHA Library, Anthea Peters, 132628

INCIDENCE OF AND RISK FACTORS FOR MAJOR HEMORRHAGE IN US VETERANS ADMINISTRATION PATIENTS WITH NEWLY DIAGNOSED CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Peter Georgantopolous, 132629

MALE GENDER IS ASSOCIATED WITH AN IMPAIRED OVERALL AND PROGRESSION FREE SURVIVAL IN PATIENTS WITH PROGNOSTIC LOW RISK CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Caspar da Cunha-Bang, 132630

BENDAMUSTINE PLUS RITUXIMAB IN 65 YEAR AND ABOVE UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS

EHA Library, Adolfo De La Fuente, 132631

ABERRANT MECHANISMS OF TELOMERE MAINTENANCE IN CHRONIC MYELOID LEUKEMIA - THE POTENTIAL ROLE OF POT1

EHA Library, Anna Deregowska, 132632

MONOCYTIC MYELOID DERIVED SUPPRESSOR CELLS (M-MDSC) AS PROGNOSTIC FACTOR IN DASATINIB TREATED PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Cesarina Giallongo, 132633

THE USE OF THE EAC PRIMERS IN DIGITAL PCR FOR MONITORING MINIMAL RESIDUAL DISEASE IN CML RESULTS IN A SHIFT BETWEEN MOLECULAR RESPONSE GROUPS.

EHA Library, Dietger Niederwieser, 132634

PRE-EXISTING SOMATIC MUTATIONS IN GENES COMMONLY MUTATED IN MYELOID MALIGNANCIES (RUNX1, DNMT3A, ASXL1) MAY CONFER BAD PROGNOSIS IN CHRONIC MYELOID LEUKEMIA.

EHA Library, Marcin Machnicki, 132635

EVOLUTION OF RUNX1 AND ASXL1 MUTATIONS DURING THE PROGRESSION OF CHRONIC MYELOID LEUKEMIA TO MYELOID BLAST PHASE: AN ANALYSIS OF 52 MATCHED PAIRED SAMPLES AT BOTH INITIAL DIAGNOSIS AND BLAST PHASE

EHA Library, Hsiao-Wen Kao, 132636

NEXT-GENERATION SEQUENCING OF AMPLIFIED DNA FRAGMENTS WITH LENGTH POLYMORPHISMS ASSOCIATED WITH CHRONIC MYELOID LEUKEMIA REVEALED POLYMORPHISMS IN REPETITIVE ELEMENTS AND CANCER RISK LOCI

EHA Library, Jitka Koblihova, 132637

DROPLET DIGITAL PCR IMPROVE MINIMAL RESIDUAL DISEASE DETECTION IN > 35% OF SAMPLES COMPARING TO RQ-PCR

EHA Library, Marcio Andrade-Campos, 132638

DROPLED DIGITAL PCR MAY HAVE A PROGNOSTIC VALUE FOR PREDICTING RELAPSE AFTER IMATINIB DISCONTINUATION

EHA Library, Carmen Fava, 132639

PROGRAMMED CELL DEATH PROTEIN 1 (PD-1) DOWNREGULATION ON REGULATORY T CELLS DURING TYROSINE KINASE INHIBITOR THERAPY IN CHRONIC MYELOID LEUKEMIA

EHA Library, Paulo Rodrigues-Santos, 132640

SINGLE NUCLEOTIDE POLYMORPHISMS IN DRUG-RELATED GENES ARE ASSOCIATED WITH RESISTANCE OR TOXICITY TO IMATINIB IN CHRONIC MYELOID LEUKAEMIA

EHA Library, Natalia Estrada, 132641

DIFFERENT SETS OF GENES WERE ASSOCIATED TO THE MOLECULAR RESPONSE AFTER 3 AND 6 MONTHS OF FIRST-LINE NILOTINIB TREATMENT BY MICROARRAY OF CD34+/LIN- CELLS OF CHRONIC PHASE CML PATIENTS AT DIAGNOSIS

EHA Library, Roberto Cairoli, 132642

MATE1 REGULATES CELLULAR UPTAKE AND SENSITIVITY TO IMATINIB IN CML PATIENTS

EHA Library, Bayram Edemir, 132643

IMPLEMENTING A CERTIFIED PLASMID REFERENCE MATERIAL FOR COPY NUMBER CALIBRATION DEMONSTRATES GOOD REPORTING CORRELATION BETWEEN %BCR-ABL/ABL (IS) AND %BCR-ABL/ABL (COPY NUMBER) IN XPERT® BCR-ABL ULTRA

EHA Library, Gwo-Jen Day, 132644

META-ANALYSIS OF THE RISKS OF ARTERIAL AND VENOUS OCCLUSIVE EVENTS WITH NEW GENERATION BCR-ABL TKIS IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA

EHA Library, Hélène Haguet, 132645

REL-PROTOCOL PHILOSOPHI34 CONFIRMS THAT NILOTINIB RAPIDLY INDUCES CD34+/LIN-PH+ CELLS DISAPPEARANCE IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA (CML) IN CHRONIC PHASE (CP).

EHA Library, Roberto Cairoli, 132646

MEANING OF MOLECULAR RESPONSES FLUCTUATION IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH LONG-TERM IMATINIB

EHA Library, Massimo Breccia, 132647

BCR-ABL FUSION TRANSCRIPT B2A2 IS ASSOCIATED WITH A HIGHER RISK OF NON-OPTIMAL EARLY RESPONSE IN CP-CML PATIENTS TREATED WITH STANDARD DOSE IMATINIB: A STUDY FROM GRUPPO TRIVENETO LMC

EHA Library, Gianni Binotto, 132648

CHRONIC MYELOID LEUKEMIA WITH EXTREME THROMBOCYTOCIS AT THE DIAGNOSIS: A NEW SUBSET

EHA Library, Federica Sora, 132649

BCR-ABL1 TRANSCRIPT LEVEL HALVING TIME IS THE ULTIMATE PROGNOSTIC FACTOR FOR ACHIEVING MAJOR AND DEEP MOLECULAR RESPONSE IN CML PATIENTS

EHA Library, Michal Gniot, 132650

MEASUREMENT OF BCR-ABL1 BY RT-QPCR IN CHRONIC MYELOID LEUKAEMIA: FINDINGS FROM AN INTERNATIONAL EQA PROGRAMME

EHA Library, Stuart Scott, 132651

VERY EARLY MOLECULAR RESPONSE AT 1 MONTH CAN PREDICT 12-MONTH MAJOR MOLECULAR RESPONSE IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA TREATED WITH TKIS

EHA Library, Hye-Young Song, 132652

PONATINIB EVALUATION AND SAFETY IN REAL LIFE CHRONIC PHASE (CP) CML PATIENTS FAILING ≥2 TYROSINE KINASE INHIBITORS (TKI): UPDATE OF THE PEARL OBSERVATIONAL STUDY

EHA Library, Franck Nicolini, 132653

IMATINIB FIRST-LINE WITH SWITCH TO 2ND GENERATION TYROSINE KINASE INHIBITORS IN CASE OF FAILURE OR TOXICITY: REAL-LIFE DATA FROM A POPULATION-BASED REGISTRY OF BCR-ABL1 + CML PATIENTS

EHA Library, Fausto Castagnetti, 132654

THE ALTERATION OF IMMUNOPROFILE DURING DASATINIB TREATMENT IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: A PROSPECTIVE OBSERVATIONAL STUDY

EHA Library, Masatomo Kuno, 132655

PLA FLOW; A FLOW CYTOMETRY-BASED ASSAY FOR DETECTION OF BCR-ABL FUSION PROTEIN IN BLOOD CELLS FROM CML PATIENTS

EHA Library, Liza Löf, 132656

COMPARISON OF PACE CLINICAL TRIAL VS REAL-WORLD PONATINIB PRESCRIBING AND DURATION OF THERAPY IN CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS

EHA Library, Michael Mauro, 132657

PATIENT-REPORTED OUTCOMES FROM AN OPEN-LABEL SAFETY AND EFFICACY STUDY OF BOSUTINIB IN PHILADELPHIA CHROMOSOME–POSITIVE CHRONIC MYELOID LEUKEMIA RESISTANT OR INTOLERANT TO PRIOR THERAPY

EHA Library, Jorge Cortes, 132658

PRELIMINARY FINDINGS FROM A CHART REVIEW OF LOWER DOSING OF PONATINIB IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS

EHA Library, Michael Mauro, 132659

IMPACT OF IMATINIB PHARMACOKINETICS ON HEALTH RELATED QUALITY OF LIFE AND ADVERSE EVENTS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Jinyi Cao, 132660

CMREGISTRY: AN OBSERVATIONAL, MULTI CENTER, PROSPECTIVE FOLLOW-UP REGISTRY OF PATIENTS WITH CHRONIC PHASE CML WITH A HIGH PROBABILITY OF OBTAINING A STABLE DEEP MOLECULAR RESPONSE >CMR4 (IS).

EHA Library, Eduardo Olavarria, 132661

BCR-ABL1 MONITORING ON THE IS USING AN ANALYTICALY AND CLINICALLY VALIDATED MULTIPLEX ASSAY DIRECTLY ALIGNED TO THE WHO PRIMARY STANDARDS

EHA Library, Justin Brown, 132662

RESULTS OF OBSERVATION WITHOUT TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS WITH DEEP MOLECULAR RESPONSE WHO STOPPED THERAPY DUE TO PREGNANCY, ADVERSE EVENTS OR BY OWN CONSIDERATION

EHA Library, Ekaterina Chelysheva, 132663

CONCURRENT OPTIMAL MOLECULAR AND CYTOGENETIC RESPONSES AT BOTH 3 AND 6 MONTHS PREDICT A HIGHER PROBABILITY OF MR4.5 ACHIEVEMENT IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB

EHA Library, Ya-Zhen Qin, 132664

THE JAK1/2 INHIBITOR RUXOLITINIB MODULATES ANTIGEN PRESENTING FUNCTIONS OF ACTIVATED PRIMARY B CELLS ON A METABOLIC LEVEL

EHA Library, Sebastian Theurich, 132665

INTRA-BONE DONOR LYMPHOCYTE INFUSION IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES RELAPSING POST ALLOHSCT

EHA Library, Andrzej Lange, 132666